Contact information
anna.schneider@rdm.ox.ac.uk
annamaria.schneider@usz.ch
+41 79 842 6787
https://orcid.org/0000-0001-6067-9658
Laboratory of Cerebral Ischemia, Room 7501, Level 7, John Radcliffe Hospital, Oxford, OX3 9DU
She/Her
Research groups
Colleges
Anna Maria Schneider
MD, PhD, MPH
ABOUT
I am a medical doctor and researcher working in neuroscience. I study the efficacy of nutritional interventions to improve acute treatment and prevention of ischemic stroke and cardiovascular disease more broadly. I am a resident in Neurology at the University Hospital in Zurich. Before starting my clinical work, I completed a PhD in the Laboratory of Cerebral Ischemia of Prof. Alastair Buchan at the University of Oxford and obtained my MPH degree from the Department of Health and Social Behavior at the Harvard T. H. Chan School of Public Health.
Recent publications
-
Preprint
Szabó FP. et al, (2024)
-
Journal article
Schneider AM. et al, (2023), Clin Med (Lond), 23, 219 - 227
-
Journal article
Schneider AM. et al, (2023), Clin Med (Lond), 23, 219 - 227
-
Journal article
Schneider AM. et al, (2023), J Neurol Neurosurg Psychiatry, 94, 267 - 271
-
Journal article
Grist JT. et al, (2023), Sci Rep, 13
-
Preprint
Schneider A. et al, (2023)
-
Preprint
Schneider A. et al, (2022)
-
Journal article
Beard DJ. et al, (2020), Stroke, 51, 2834 - 2843
-
Journal article
Schneider AM. et al, (2020), Stroke, 51
-
Rapamycin Improves Post-Recanalization Blood Flow After Acute Experimental Stroke in Rats
Conference paper
Schneider AM. et al, (2020), STROKE, 51